news

« BACK

Health



Results 1 - 20 of 67.
1 2 3 4 Next »


Pharmacology - Health - 10.02.2020
VIB works on antiviral drug aimed to halt coronavirus outbreak
The lab of professor Xavier Saelens (VIB-Ghent University) is quickly mobilizing to try to find a treatment for the viral infection caused by the corona virus. Since the coronavirus (2019-nCoV) outbreak was reported by China in December 2019, the number of confirmed cases of the virus is increasing rapidly, with cases now reported in 28 countries.

Health - Life Sciences - 29.01.2020
Defective cellular transport system as a new cause of Parkinson’s disease
Biomedical scientists at KU Leuven have discovered that a defect in the ATP13A2 gene causes cell death by disrupting the cellular transport of polyamines. When this happens in the part of the brain that controls body movement, it can lead to Parkinson's disease. With more than six million patients around the world, Parkinson's disease is one of the most common neurodegenerative disorders.

Health - Pharmacology - 23.01.2020
Preventing metastasis by stopping cancer cells from making fat
In brief  (18 seconds of reading): Olivier Feron , a UCLouvain researcher, studies how cancer spreads through the body via metastasis His major discovery was that cancer cells multiply by using lipids as food. His latest discovery, published in the scientific , is that lipid storage promotes cancer invasiveness A new drug currently being tested to treat obesity may also help fight metastasis Olivier Feron, a researcher at the University of Louvain (UCLouvain) Institute of Experimental and Clinical Research, seeks to understand how metastases form from a tumour.

Health - 22.01.2020
Europe is ready to respond to Coronavirus outbreak
Europe is ready to respond to Coronavirus outbreak
Herman Goossens (UAntwerp) is following the events closely to ensure health and security of European citizens.

Health - Pharmacology - 21.01.2020
Leuven researchers present technique to grow tissue implants for bone defects
Researchers from KU Leuven and University Hospitals Leuven have managed to engineer living implants in the lab by mimicking how bone tissue is created in an embryo. The technology paves the way for bone-regenerating tissue implants created on an industrial scale using 3D bioprinting. The researchers expect the first living implants to be available to patients in four years.

Health - 21.01.2020
’Love hormone’ improves attachment issues in people with autism
Oxytocin, often dubbed the 'love hormone', is known to promote social bonding. Researchers at KU Leuven have now discovered that administering oxytocin to adult men with autism makes them more open to close emotional bonds with others. The hormone has positive long-term effects as well.  A team led by Professor Kaat Alaerts (KU Leuven) recruited 40 adult men with autism spectrum disorder to take part in their study.  "In a first stage, we examined the amount of oxytocin produced by the participants themselves.

Life Sciences - Health - 14.01.2020
New strategy in the fight against antibiotic resistance
Bioscience engineers from KU Leuven in Belgium have developed a new antibacterial strategy that weakens bacteria by preventing them from cooperating. Unlike with antibiotics, there is no resistance to this strategy, because the non-resistant bacteria outnumber resistant ones. The findings are published.

Health - Physics - 09.01.2020
Copper-based nanomaterials can kill cancer cells in mice
An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.

Pharmacology - Health - 31.12.2019
New drug targets sleeping sickness
Antwerp and Ghent scientists discover new drug for deadly disease. Antwerp and Ghent scientists have discovered a new drug against African 'sleeping sickness'. "This disease seems to be on its way out, but it is still very useful to have a new drug to fall back on, because we can't rule out another sudden upswing ", says Prof. Guy Caljon (UAntwerp).

Health - 19.12.2019
UAntwerp and UZA to store six million samples in Antwerp Biobank
Wednesday 18 December saw the official inauguration of the Antwerp Biobank, a joint UZA/UAntwerp project. The biobank is invaluable in terms of scientific research and medical progress. The brand-new Antwerp Biobank processes and stores a wide range of high-quality human bodily material. This may be what's known as residual material, which is any bodily material that remains after a diagnostic examination or medical procedure, but most samples have been prospectively collected for research purposes.

Pharmacology - Health - 16.12.2019
Immunotherapy: a promising alternative
In brief  (20 seconds of reading) : Since 2004, Sophie Lucas, a researcher at the UCLouvain de Duve Institute, has been studying the immune responses that cancer patients can develop against their own tumour She is currently testing a new anti-cancer drug that would strengthen such immune responses This research won the prestigious Academy of Medicine GSK Award , which recognises work in the fields of vaccinology and immunology Sophie Lucas , a researcher at the UCLouvain de Duve Institute , studies the immune responses that cancer patients can develop against their own tumour.

Pharmacology - Health - 16.12.2019
Flu antiviral has bigger benefits for sicker, older patients
A Europe-wide study conducted over three flu seasons finds that the antiviral drug Tamiflu can help people recover from flu-like illness about one-day sooner on average. Published today in The Lancet, the European Commission-funded ‘ALIC4E' study was led by the Universities of Oxford (UK) and Utrecht (The Netherlands).

Life Sciences - Health - 26.11.2019
A protein tag to study the immune system
Researchers from VIB-Ghent Universitiy Center for Medical Biotechnology and other collaborators, developed a novel approach to better understand a basic defense mechanism of our immune system. Central is ISG15, a small protein with a role in the immune system. With the newly developed method, scientists can now identify and study proteins tagged with ISG15, allowing them to unravel its many functions in fighting disease, potentially leading to novel antimicrobial drugs.

Health - Life Sciences - 19.11.2019
KU Leuven researchers receive 3 million dollars to fight Crohn’s disease
Why do some patients with Crohn's disease still suffer from abdominal pain, even when their treatment is successful? With funding from the Helmsley Charitable Trust, researchers from Belgium and Sweden will spend the next three years examining the underlying mechanisms of this pain. Approximately 3 out of 1000 people have Crohn's disease, which is characterised by intestinal inflammation.

Life Sciences - Health - 29.10.2019
Electrodes to study how our brain recognises objects
Electrodes to study how our brain recognises objects
For the first time ever, researchers from KU Leuven have carried out tests on human brains in the area that is responsible for our vision. This research method is unique. The results have been published in PLOS Biology . To gain a better understanding of the human brain, researchers can rely on several methods.

Health - 22.10.2019
Anti-arthritis drug also stops tuberculosis bacillus from multiplying in blood stem cells
Immunologist Johan Van Weyenbergh (KU Leuven) and his Belgian-Brazilian colleagues have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect and hijack blood stem cells. Tuberculosis (TB) may affect any part of the body, but the spread of the disease might start in the bone marrow.

Life Sciences - Health - 14.10.2019
The electric switches in our brain need lipids
Our brain cells, and more specifically the channel proteins in the cell wall, need lipids - or fat - to function properly. These are the findings of an international study led by the Laboratory of Structural Neurobiology at KU Leuven. The researchers identified the structure of these proteins in the presence of a lipid molecule at the atomic level for the first time.

Life Sciences - Health - 14.10.2019
Stem cell researchers identify possible mechanism of neurocognitive problems in Duchenne muscular dystrophy
Research at KU Leuven suggests a cause for the neurodevelopmental disturbances experienced by a third of patients with Duchenne muscular dystrophy. The discovery suggests possible underlying mechanisms of these problems, which appear targetable by therapeutic interventions in a cellular model.  Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder in which the muscles, including the heart and respiratory muscles, progressively become weaker.

Health - Life Sciences - 19.09.2019
One step closer to treating and preventing stomach flu thanks to new research model
One step closer to treating and preventing stomach flu thanks to new research model
Researchers at KU Leuven have developed a new research model to grow and study the human variant of the norovirus. The virus could thus far only be studied through a variant that occurs in mice. The new model, that is described in the journal PLOS Pathogens, should allow researchers to develop a treatment for stomach flu.

Pharmacology - Health - 11.09.2019
Can a DNA construction kit replace expensive antibody medication?
Researchers at KU Leuven have developed a technique to make sheep produce new antibodies simply by injecting the DNA building blocks. This approach is much cheaper and more efficient than producing antibodies industrially and administering them afterwards. The study in animals with a similar size as humans brings us a step closer to the clinical use of antibody gene therapy.
1 2 3 4 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |